Additionally, studies involving interventions such as RES, Zhenwu decoction, Chinese angelica (CHA), and Fructus aurantii (FRA) all highlight PPARG and AKT1 as common targets, emphasizing their potential therapeutic significance in various conditions including diabetic kidney disease and colorectal cancer [19–21]. This evidence concerns the gene AKT1 and diabetic kidney disease.